A surgical robot is not an autonomous machine. It is a set of wristed instruments and a magnified three-dimensional camera, controlled in real time by a surgeon sitting a few metres away. Understanding that one fact answers most of the questions patients ask — including the important one: does it make the cancer operation itself better?
What you'll read
What the robot actually does
The surgeon's hand movements are scaled down and filtered for tremor, then reproduced by instruments that bend in ways a human wrist cannot inside a narrow space. The camera gives depth perception that standard laparoscopy lacks. In practice this makes fine work — sewing, dissecting close to nerves, operating deep in the pelvis — considerably easier.
Which cancers benefit most
- Prostate cancer — the operation where robotic surgery became standard, thanks to nerve-sparing precision that affects continence and potency.
- Kidney cancer — partial nephrectomy, removing the tumour while preserving working kidney.
- Uterine and cervical cancer — shorter stay and faster return to work in selected early-stage cases.
- Rectal cancer — deep pelvic dissection where the robot's articulation genuinely helps.
- Selected lung, oesophageal, gastric and head-and-neck operations in high-volume centres.
What the evidence really shows
Across most studies, robotic operations produce less blood loss, smaller scars, less pain and a shorter hospital stay than open surgery. What they generally do not show is a higher cure rate: long-term survival after a robotic and an open operation for the same tumour is broadly similar when both are done well.
There is one important caution. In early cervical cancer, a large randomised trial found worse outcomes after minimally invasive radical hysterectomy than after open surgery, and guidelines changed accordingly. It is a reminder that the approach must be chosen per cancer, not applied everywhere because the technology exists.
Judge the surgeon, not the machine
Every hospital advertises the same robot; the outcomes differ because of who is sitting at the console. Volume is the single best proxy for quality in cancer surgery. Ask directly:
- How many of this exact operation do you perform each year?
- What proportion of your cases end with clear surgical margins?
- What is your rate of conversion to open surgery, and of major complications?
- Will you personally be at the console for my operation?
- How many of these cases does the hospital do as a team, including anaesthesia and pathology?
Recovery and cost
Typical hospital stay after a robotic cancer operation is one to four days, with a return to light activity in two to three weeks. For international patients that usually means planning ten to fourteen days in the country: a day for the pre-operative work-up, the operation, the inpatient days, a wound check, and the pathology result before flying home.
In the United States a robotic cancer operation is frequently billed between $30,000 and $80,000 including the hospital stay. At accredited private hospitals in İstanbul the same procedure with an experienced high-volume surgeon typically falls between $8,000 and $20,000, and the quote should say explicitly whether pathology, the first follow-up and any stent or drain removal are included.
Frequently asked questions
Does the robot operate by itself?
No. Every movement is made by the surgeon in real time; the system cannot act on its own and stops the moment the surgeon's hands leave the controls. A full surgical team remains at the operating table throughout.
Is robotic surgery always better than laparoscopy?
Not always. For many abdominal operations conventional laparoscopy gives equivalent results at lower cost. The robot's advantage grows where space is tight and precision matters most — the pelvis, the kidney hilum, nerve-sparing dissection.
Are robotic systems available in Türkiye?
Yes. Major private hospital groups in İstanbul and Ankara have operated robotic programmes for years, and several of their urology and gynaecologic oncology surgeons perform hundreds of robotic cases annually — which is the number that matters.
Is robotic surgery right for your case?
Send your imaging and pathology. A surgical oncologist will tell you whether the robotic approach is indicated — and how many such operations the proposed surgeon performs each year.